BR100 Increased By (0.01%)
BR30 Increased By (0.53%)
KSE100 Increased By (0.28%)
KSE30 Increased By (0.29%)
AGHA 6.38 Increased By ▲ 0.06 (0.95%)
BECO 4.35 Increased By ▲ 0.08 (1.87%)
BML 62.55 Increased By ▲ 0.10 (0.16%)
BOP 31.39 Increased By ▲ 0.16 (0.51%)
CNERGY 11.73 Increased By ▲ 0.14 (1.21%)
CSIL 5.91 Increased By ▲ 0.19 (3.32%)
FCCL 61.71 Increased By ▲ 0.17 (0.28%)
FFL 14.79 Decreased By ▼ -0.23 (-1.53%)
FNEL 1.24 Increased By ▲ 0.01 (0.81%)
KEL 6.32 Increased By ▲ 0.06 (0.96%)
KOSM 5.90 Increased By ▲ 0.34 (6.12%)
LOTCHEM 24.69 Increased By ▲ 0.01 (0.04%)
MLCF 103.93 Decreased By ▼ -0.15 (-0.14%)
NBP 173.32 Decreased By ▼ -1.96 (-1.12%)
NCPL 51.83 Decreased By ▼ -0.94 (-1.78%)
NPL 54.03 Decreased By ▼ -0.09 (-0.17%)
OGDC 315.87 Increased By ▲ 2.48 (0.79%)
PACE 9.26 Increased By ▲ 0.06 (0.65%)
PAEL 35.58 Decreased By ▼ -0.22 (-0.61%)
PIBTL 13.66 Increased By ▲ 0.19 (1.41%)
PPL 226.07 Increased By ▲ 4.26 (1.92%)
PRL 80.28 Increased By ▲ 1.20 (1.52%)
PTC 46.64 Decreased By ▼ -0.21 (-0.45%)
SSGC 23.82 Decreased By ▼ -0.05 (-0.21%)
TBL 9.24 Decreased By ▼ -0.07 (-0.75%)
TELE 7.55 Increased By ▲ 0.16 (2.17%)
TPL 24.54 Decreased By ▼ -0.57 (-2.27%)
TPLP 12.99 Increased By ▲ 0.48 (3.84%)
TREET 25.98 Decreased By ▼ -0.27 (-1.03%)
TRG 53.33 Decreased By ▼ -0.11 (-0.21%)

ISLAMABAD: The Competition Commission of Pakistan (CCP) has recovered Rs30 million from a leading multinational fast-moving consumer goods (FMCG) company following a Competition Appellate Tribunal (CAT) ruling upholding the Commission’s finding of deceptive marketing in relation to one of its consumer products.

The recovery follows the Tribunal’s decision on an appeal against CCP’s order dated February 9, 2021, in which the Commission had found the company guilty of disseminating misleading information to consumers regarding the nature and characteristics of the product, in violation of Section 10 (2) (b) of the Competition Act, 2010.

According to the Tribunal’s judgment, the company had marketed the product in a manner that created the impression that it possessed medicinal properties despite its status as a non-medicated consumer product currently registered in the food category.

The Tribunal directed the company to pay a penalty of Rs30 million and comply with the corrective measures prescribed by the Commission within the stipulated timeframe.

The case originated from a complaint alleging that the company’s advertising and marketing campaigns misled consumers regarding the product’s regulatory status and characteristics.

The Tribunal also noted that the company had introduced significant changes to its packaging and consumer disclosures following CCP’s proceedings. These changes included the prominent display of a “Non-Medicated” disclaimer in both English and Urdu on product packaging and blister packs to improve consumer awareness and transparency.

As part of CCP’s directions, the company has also been required to publicly notify consumers through advertisements in widely circulated English and Urdu newspapers regarding the change in the product’s status from a medicated/drug category to a food category until full compliance is achieved.

The recovery underscores CCP’s ongoing efforts to protect consumers from deceptive marketing practices and ensure that businesses provide accurate, clear, and truthful information about their products and services.

Copyright Business Recorder, 2026

Comments

200 characters remaining